Zachary Prutch

Zachary Prutch is a Clinical Program Manager with extensive experience in clinical operations and management within the pharmaceutical industry. Currently at Akero Therapeutics since April 2023, Zachary serves as the key operational contact for a Global Phase 3 study, overseeing site selection and implementation. Previously, at PharmaEssentia from March 2022 to April 2023, Zachary managed the strategic planning and execution of Phase II and III hematology oncology trials. Zachary's early career includes roles at The Janssen Pharmaceutical Companies, Parexel, Quintiles, Aerotek, and the University of Colorado Cancer Center, where responsibilities ranged from site management to clinical trial oversight across various oncology studies. Zachary holds a Bachelor of Science in Biology with a focus on Molecular and Cellular from Colorado State University Pueblo.